Stock listing

Biomarin Pharmaceutical Inc.

Selected listing: 924801 · LS · EUR · DE

Biomarin Pharmaceutical Inc. (Lang & Schwarz: 924801), Health Technology. Latest release Oct 5, 2026: BioMarin Appoints Cara Bauer as Chief People Officer.

924801:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: 924801
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Biomarin Pharmaceutical Inc.

BioMarin Appoints Cara Bauer as Chief People Officer

October 5, 2026

BioMarin Appoints Cara Bauer as Chief People Officer

October 4, 2026

BioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress

October 2, 2026

BioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress

October 1, 2026

Profluent Partners With BioMarin to Design Novel Medicines Using AI

September 30, 2026

All Biomarin Pharmaceutical Inc. news →

Events

Replays

BioMarin Pharmaceutical Inc. (BMRN) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 04:30 PM ET
Watch
BioMarin Pharmaceutical Inc. (BMRN) Q1 2026 Earnings Call
Mon, May 04, 2026 · 04:30 PM ET
Watch
BioMarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Call
Mon, Feb 23, 2026 · 04:30 PM ET
Watch

Research Biomarin Pharmaceutical Inc.

Biomarin Pharmaceutical Inc. company profile

View the public company page for Biomarin Pharmaceutical Inc. on 6ix.

Biomarin Pharmaceutical Inc. news

Read company news and market updates connected to Biomarin Pharmaceutical Inc..

Biomarin Pharmaceutical Inc. investor events

Find investor webinars, events, and replay context for Biomarin Pharmaceutical Inc..